Biomarker-directed
Showing 1 - 25 of 6,098
Renal Injury, Acute Kidney Injury Trial (Goal Directed Fluid Therapy)
Not yet recruiting
- Renal Injury
- Acute Kidney Injury
- Goal Directed Fluid Therapy
- (no location specified)
Oct 25, 2023
Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based
Not yet recruiting
- Breast Cancer
- Cancer of the Breast
- VENTANA MIB-1 Ki67 assay
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Apr 18, 2023
Amyotrophic Lateral Sclerosis Trial in Toronto (Repetitive Transcranial Magnetic Stimulation)
Recruiting
- Amyotrophic Lateral Sclerosis
- Repetitive Transcranial Magnetic Stimulation
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Aug 8, 2023
Bladder Transitional Cell Carcinoma, Bladder Cancer, Fibroblast Growth Factor Receptor Trial (Infigratinib)
Withdrawn
- Bladder Transitional Cell Carcinoma
- +2 more
- (no location specified)
Aug 8, 2022
Cardiotoxicity, HER2-positive Breast Cancer Trial in Aarhus, Herlev, Odense (Biomarkers: Troponins and natriuretic peptides)
Recruiting
- Cardiotoxicity
- HER2-positive Breast Cancer
- Biomarkers: Troponins and natriuretic peptides
-
Aarhus, Denmark
- +2 more
Jun 3, 2022
Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)
Active, not recruiting
- Muscle Invasive Bladder Cancer
- AZD4547
- +6 more
-
Los Angeles, California
- +26 more
Oct 17, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- SY-1425 (tamibarotene)
- +2 more
-
Hartford, Connecticut
- +25 more
May 4, 2022
Plasma Genotyping asNoninvasive Biomarker for Genotype-directed
Recruiting
- NSCLC
- Melanoma
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 1, 2022
Alzheimer Trial in Australia (XPro1595)
Completed
- Alzheimer Disease
-
Macquarie Park, New South Wales, Australia
- +4 more
Feb 16, 2022
Asthma Attack, Asthma Trial in Singapore (Standard care, Eosinophil-directed care)
Recruiting
- Asthma Attack
- Asthma
- Standard care
- Eosinophil-directed care
-
Singapore, Singapore
- +1 more
Nov 15, 2022
NSCLC Trial in Canada, United States (Pembrolizumab)
Active, not recruiting
- Non-Small Cell Lung Cancer
-
Baltimore, Maryland
- +5 more
Apr 7, 2022
Metastatic Colorectal Cancer Trial in Austria (FOLFIRI + Cetuximab, modifiedFOLFOX6 + Cetuximab)
Completed
- Metastatic Colorectal Cancer
- FOLFIRI + Cetuximab
- modifiedFOLFOX6 + Cetuximab
-
Linz, Oberösterreich, Austria
- +10 more
Dec 18, 2020
Malignant Tumor Trial in Philadelphia (other, drug, procedure)
Completed
- Malignant Neoplasm
- cytology specimen collection procedure
- +3 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Feb 3, 2021
Advanced NSCLC Trial in Worldwide (Pembrolizumab, Favezelimab, Lenvatinib)
Active, not recruiting
- Advanced Non-Small Cell Lung Cancer
- Pembrolizumab
- +3 more
-
Tempe, Arizona
- +80 more
Aug 23, 2022
Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States (drug, other,
Recruiting
- Invasive Breast Carcinoma
- +11 more
- Chemotherapy
- +4 more
-
Conroe, Texas
- +4 more
May 3, 2022
NSCLC Trial in United States
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Daphne, Alabama
- +16 more
May 30, 2023
Esophageal Cancer Trial (BIRC3)
Not yet recruiting
- Esophageal Cancer
- BIRC3
- (no location specified)
Apr 16, 2020
EGFR Activating Mutation, Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Winston-Salem (drug, biological,
Terminated
- EGFR Activating Mutation
- +2 more
- Chemotherapy
- +6 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jan 28, 2021
NSCLC Trial in United States
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
-
Daphne, Alabama
- +17 more
Nov 30, 2022
Pulmonary Embolism Trial in Milano (ultrasound-assisted, catheter-directed thrombolysis)
Recruiting
- Pulmonary Embolism
- ultrasound-assisted, catheter-directed thrombolysis
-
Milano, Italia, ItalyASST GOM Niguarda
Nov 21, 2023
Medicare Anti-Aß mAb Coverage With Evidence Development Study
Recruiting
- Mild Alzheimer's Disease
- Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
- Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
-
Baltimore, MarylandCenters for Medicare and Medicaid Services
Sep 21, 2023
Biomarker for Infection Risk in CLL and MM
Not yet recruiting
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Screening
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
May 3, 2023
Cardiovascular Diseases Trial in New York (Portable air cleaner (PAC), Sham Portable air cleaner (PAC))
Enrolling by invitation
- Cardiovascular Diseases
- Portable air cleaner (PAC)
- Sham Portable air cleaner (PAC)
-
New York, New YorkNYU Langone Health
Nov 22, 2022
Analysis of Cardiac Biomarker Racial Discrepancies
Enrolling by invitation
- Heart Failure
- No intervention
-
Dallas, TexasMethodist Dallas Medical Center
Dec 20, 2022